logo

Prothena Corporation Plc (PRTA)



Trade PRTA now with
  Date
  Headline
9/28/2022 12:18:14 PM Prothena Shares Soar 70%
3/28/2022 8:57:38 AM Prothena Initiates Phase 1 SAD Study Of PRX012, Under Investigation For Treatment Of Alzheimer’s Disease
9/28/2021 3:10:15 AM Prothena Reclaims Lost Glory
7/12/2021 7:26:49 AM Novo Nordisk Buys Prothena's Clinical Stage Antibody PRX004 And Broader ATTR Amyloidosis Programme
5/9/2018 7:52:57 AM Wedbush Is Cutting Prothena Corporation plc (PRTA) FY18 Rev. Estimate To 1.4 M From 101.6 M
5/9/2018 7:52:41 AM Wedbush Is Lowering Prothena Corporation plc (PRTA) Q4 18 Rev. Estimate To 0.4 M From 25.4 M
5/9/2018 7:52:35 AM Wedbush Is Cutting Prothena Corporation plc (PRTA) Q3 18 Rev. Estimate To 0.4 M From 25.4 M
5/9/2018 7:52:27 AM Wedbush Is Cutting Prothena Corporation plc (PRTA) Q2 18 Rev. Estimate To 0.4 M From 25.4 M
5/9/2018 7:51:56 AM Wedbush Is Cutting Prothena Corporation plc (PRTA) FY18 Estimate To -3.54 From -2.87
5/9/2018 7:51:39 AM Wedbush Is Cutting Prothena Corporation plc (PRTA) Q4 18 Estimate To -0.51 From -0.50
5/9/2018 7:51:18 AM Wedbush Is Cutting Prothena Corporation plc (PRTA) Q2 18 Estimate To -1.05 From -0.83
5/9/2018 7:50:45 AM Wedbush Reiterates Prothena Corporation plc (PRTA) At Neutral With $13 Price Target
4/23/2018 1:42:40 PM Jefferies Is Raising Prothena Corporation plc (PRTA) FY19 Estimate To -3.55 From -5.28
4/23/2018 1:42:25 PM Jefferies Is Increasing Prothena Corporation plc (PRTA) FY18 Estimate To -4.92 From -5.62
4/23/2018 1:41:35 PM Jefferies Lowers Prothena Corporation plc (PRTA) To Hold From Buy With $12 Price Target